Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-04

Clinical Trial Update: Estradiol Levels in Patients Treated With Estring [Phase 2]

View source ↗

Summary

Phase 2 trial results on estradiol levels in patients treated with Estring have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRING (Estradiol)

Snippet

Sponsor: University of Arizona | Conditions: Estrogen Levels Among Breast Cancer Patients | Phase 2 | Status: COMPLETED | Results posted: 2022-02-04